Author:
Hwang Ju-Mi,Lee Woo-Jin,Jo Jae-Hwan,Uwamahoro Claudine,Jang Seung-Ik,Jung Eun-Ju,Bae Jeong-Won,Kim Dae-Hyun,Yi Jun Koo,Ha Jae Jung,Oh Dong Yep,Kwon Woo-Sung
Reference31 articles.
1. Design, synthesis and antimycobacterial activity evaluation of natural oridonin derivatives;Xu;Bioorg. Med. Chem. Lett.,2014
2. Anti-proliferative effects of oridonin on SPC-A-1 cells and its mechanism of action;Liu;J. Int. Med. Res.,2004
3. Oridonin: a review of its pharmacology, pharmacokinetics and toxicity;Li;Front. Pharmacol.,2021
4. Oridonin inhibits aberrant AKT activation in breast cancer;Sun;Oncotarget,2018
5. Oridonin improves the sensitivity of multiple myeloma cells to bortezomib through the PTEN/PI3K/Akt pathway;Wu;Curr. Top. Nutraceutical Res.,2020